Phase II trial of nomacopan in bullous pemphigoid meets primary and key secondary efficacy endpoints May 4, 2020 No Comments
Amryt closes enrollment in phase III EASE trial of AP-101 for epidermolysis bullosa April 23, 2020 No Comments
Phase II study of vixarelimab in prurigo nodularis meets primary efficacy endpoint April 23, 2020 No Comments
Shenzhen Edk Pharmaceutical Technology patents androgen receptor antagonists April 16, 2020 No Comments
RSS